Diabetes 51:3290-3299, 2002
© 2002 by the American Diabetes Association, Inc.
Activation of Cyclin D1-Cdk4 and Cdk4-Directed Phosphorylation of RB Protein in Diabetic Mesangial Hypertrophy
Denis Féliers1,2,
Meredith A. Frank2, and
Daniel J. Riley1,2
1 Department of Medicine, Division of Nephrology, South Texas Veterans Health Care System, San Antonio, Texas
2 University of Texas Health Science Center at San Antonio, San Antonio, Texas
To determine the role of cell-cycle proteins in regulating pathological renal hypertrophy, diabetes was induced in mice expressing a human retinoblastoma (RB) transgene and in wild-type littermates. Whole-kidney and glomerular hypertrophy caused by hyperglycemia was associated with specific G1 phase cell-cycle events: early and sustained increase in expression of cyclin D1 and activation of cyclin D1-cdk4 complexes, but no change in expression of cyclin E or cdk2 activity. Overexpression of RB alone likewise caused hypertrophy and increased only cyclin D1-cdk4 activity; these effects were not further augmented by high glucose. Identical observations were made when isolated mesangial cells conditionally overexpressing RB from a tetracycline-repressible system hypertrophied in response to high glucose. A mitogenic signal in the same cell-culture system, in contrast, transiently and sequentially activated both cyclin D1-cdk4 and cyclin E-cdk2. In vivo and in cultured mesangial cells, high glucose resulted in persistent partial phosphorylation of RB, an event catalyzed specifically by cyclin D1-cdk4. These data indicate that mesangial hypertrophy caused by hyperglycemia in diabetes results in sustained cyclin D1-cdk4-dependent phosphorylation of RB and maintenance of mesangial cells in the early-to-middle G1 phase of the cell cycle.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M.-J. Lee, D. Feliers, M. M. Mariappan, K. Sataranatarajan, L. Mahimainathan, N. Musi, M. Foretz, B. Viollet, J. M. Weinberg, G. G. Choudhury, et al.
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy
Am J Physiol Renal Physiol,
February 1, 2007;
292(2):
F617 - F627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Kasinath, M. M. Mariappan, K. Sataranatarajan, M. J. Lee, and D. Feliers
mRNA Translation: Unexplored Territory in Renal Science
J. Am. Soc. Nephrol.,
December 1, 2006;
17(12):
3281 - 3292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Korrapati, J. Chilakapati, E. A. Lock, J. R. Latendresse, A. Warbritton, and H. M. Mehendale
Preplaced cell division: a critical mechanism of autoprotection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death in mice
Am J Physiol Renal Physiol,
August 1, 2006;
291(2):
F439 - F455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Korrapati, E. A. Lock, and H. M. Mehendale
Molecular mechanisms of enhanced renal cell division in protection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death
Am J Physiol Renal Physiol,
July 1, 2005;
289(1):
F175 - F185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Geoffroy, N. Wiernsperger, M. Lagarde, and S. El Bawab
Bimodal Effect of Advanced Glycation End Products on Mesangial Cell Proliferation Is Mediated by Neutral Ceramidase Regulation and Endogenous Sphingolipids
J. Biol. Chem.,
August 13, 2004;
279(33):
34343 - 34352.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|